0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

Pharmaceutical API Manufacturing Market Report 2025 - Product Thumbnail Image

Pharmaceutical API Manufacturing Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Nebulizer Market Report and Forecast 2023-2031 - Product Thumbnail Image

Nebulizer Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
EUR$4,949USDGBP
Controlled Release Drug Delivery Market Report and Forecast 2024-2032 - Product Thumbnail Image

Controlled Release Drug Delivery Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 140 Pages
  • Global
From
EUR$4,969USDGBP
Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Regional Outlook and Forecast, 2022-2028 - Product Thumbnail Image

Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Regional Outlook and Forecast, 2022-2028

  • Report
  • January 2023
  • 191 Pages
  • Global
From
EUR$3,600USDGBP
Europe Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 75 Pages
  • Europe
From
EUR$1,500USDGBP
LAMEA Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

LAMEA Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 75 Pages
  • Africa, Middle East
From
EUR$1,500USDGBP
Asia Pacific Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Asia Pacific Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 75 Pages
  • Asia Pacific
From
EUR$1,500USDGBP
North America Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

North America Nebulizer Market Size, Share & Industry Trends Analysis Report By Type, By End-use, By Application, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 64 Pages
  • North America
From
EUR$1,500USDGBP
Europe Smart Inhalers Market Size, Share & Industry Trends Analysis Report By Product, By Disease Indication, By Distribution Channel, By Country and Growth Forecast, 2021-2027 - Product Thumbnail Image

Europe Smart Inhalers Market Size, Share & Industry Trends Analysis Report By Product, By Disease Indication, By Distribution Channel, By Country and Growth Forecast, 2021-2027

  • Report
  • March 2022
  • 90 Pages
  • Europe
From
EUR$1,500USDGBP
Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 814 Pages
  • Global
From
EUR$2,500USDGBP
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 194 Pages
  • Global
From
EUR$5,850USDGBP
Inhaled and Intranasal Products Contract Service Providers - Global Strategic Business Report - Product Thumbnail Image

Inhaled and Intranasal Products Contract Service Providers - Global Strategic Business Report

  • Report
  • July 2025
  • 298 Pages
  • Global
From
EUR$5,850USDGBP
Smart Inhalers Market to 2027 - Global Analysis and Forecasts by Product; Disorder; End User and Geography - Product Thumbnail Image

Smart Inhalers Market to 2027 - Global Analysis and Forecasts by Product; Disorder; End User and Geography

  • Report
  • June 2019
  • 144 Pages
  • Global
From
EUR$4,450USDGBP
Asthma Drugs Market Report 2025 - Product Thumbnail Image

Asthma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 518 Pages
  • Global
From
EUR$2,000USDGBP
Oral Transmucosal Drugs Market by Product Type, Route of Administration, Indication, Distribution Channel, and By Region - Product Thumbnail Image

Oral Transmucosal Drugs Market by Product Type, Route of Administration, Indication, Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
Cough and Cold Preparations Market Report 2025 - Product Thumbnail Image

Cough and Cold Preparations Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
HP (High Potency) APIs Market Report 2025 - Product Thumbnail Image

HP (High Potency) APIs Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033

  • Report
  • February 2025
  • 150 Pages
  • Global
From
EUR$2,999USDGBP
Pharmaceutical Drugs Market Report 2025 - Product Thumbnail Image

Pharmaceutical Drugs Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
EUR$4,490USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more